✦ LIBER ✦

433 Recurrence Score (RS) and Treatment Decisions in Node-positive (N+), Estrogen Receptor-positive (ER+) Breast Cancer Patients in Israel

✍ Scribed by S.M. Stemmer; N. Lieberman; N. Efrat; D.B. Geffen; M. Steiner; L. Soussan-Gutman; S. Merling; S. Rizel; S.H. Klang

Book ID: 117662340
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 59 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(12)70499-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P206 German multicentre decision impact

P206 German multicentre decision impact study of Oncotype DX recurrence score (RS) on adjuvant treatment in estrogen receptor positive (ER+) node negative (N0) and node positive (N+) early breast cancer

✍ J.-U. Blohmer; T. Kühn; M. Rezai; S. Kümmel; M. Warm; H. Eggemann; K. Friedrichs 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Association Between the 21-Gene Recurren

Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

✍ Mamounas, E. P.; Tang, G.; Fisher, B.; Paik, S.; Shak, S.; Costantino, J. P.; Wa 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 256 KB

Disease burden and treatment outcomes in

Disease burden and treatment outcomes in second-line therapy of patients with estrogen receptor-positive (ER+) advanced breast cancer: A review of the literature

✍ Kimberly A. Boswell; Xufang Wang; Manasee V. Shah; Matti S. Aapro 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Treatment of metastatic breast cancer in

Treatment of metastatic breast cancer in estrogen receptor positive patients a randomized trial comparing tamoxifen alone versus tamoxifen plus CMF

✍ W. R. Bezwoda; D. Derman; N. G. De Moor; M. Lange; J. Levin 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 2 views

Prognostic and predictive value of the 2

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

✍ Kathy S Albain; William E Barlow; Steven Shak; Gabriel N Hortobagyi; Robert B Li 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 165 KB

P198 Prospective trans-GEICAM study of t

P198 Prospective trans-GEICAM study of the impact of the 21-gene recurrence score assay and traditional clinico-pathological factors on clinical decision making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer

✍ J. Albanell; R. Colomer; M. Ruiz-Borrego; E. Alba; J.A. García Saenz; M. Martin; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB